ESTRO 2025 - Abstract Book

S985

Clinical – Head & neck

ESTRO 2025

Conclusion: Our retrospective study offers valuable insights into survival outcomes and prognostic factors for oral tongue squamous cell carcinoma (SCC) patients treated with surgery, intensity-modulated radiotherapy (IMRT), and chemotherapy. The findings highlight the critical roles of nodal status, tumor characteristics, and treatment modalities in determining patient prognosis. Despite the study's limitations, these results contribute to a deeper understanding of the factors influencing survival and recurrence in oral tongue SCC, supporting future research and informing clinical management strategies.

Keywords: Tongue cancer, radiotherapy, chemotherapy

1633

Digital Poster Fear of cancer recurrence in adults with HPV-positive oropharyngeal cancer after (chemo)radiation – A bicentric cross-sectional observational study Alexander Rühle 1,2 , Anna Boide 1,2 , Georg Wurschi 3,4 , Charlotte Pannenbecker 1 , Anna-Maria Tews 1 , Clemens Seidel 1,2 , Andreas Dietz 5,2 , Orlando Guntinas-Lichius 6,4 , Anja Mehnert-Theuerkauf 7,2 , Klaus Pietschmann 3,4 , Nils H Nicolay 1,2 1 Department of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany. 2 Partner Site Leipzig, Comprehensive Cancer Center Central Germany, Leipzig, Germany. 3 Department of Radiotherapy and Radiation